Publication de 4 numéros par an
ISSN Imprimer: 0893-9675
ISSN En ligne: 2162-6448
Indexed in
Targeting the Insulin-like Growth Factor Receptor: Developing Biomarkers from Gene Expression Profiling
RÉSUMÉ
Overwhelming evidence implicates insulin-like growth factor (IGF) signaling in the growth and survival of many types of human cancer cells. Numerous inhibitors of the IGF1 receptor (IGF1R) have been developed, and they displayed remarkable antineoplastic activity in preclinical models and promising success in early phase clinical trials. However, while responses have been observed in numerous cancer types, they have occurred in a minority of patients, and serious toxicities have been observed. Identifying patients likely to benefit from anti-IGF1R therapy requires further characterizing the role of IGF1 signaling in various stages of tumorigenesis in order to identify critical downstream factors that may be used as predictors of response, or to serve as novel therapeutic targets. Recent microarray analyses have begun to unravel expression "signatures" specific for IGF1 that correlate with poor breast cancer prognosis and with response to anti-IGFIR inhibitors. In this review we briefly discuss the history of the IGF1 family in neoplasia, how it is targeted, results from clinical trials, and the quest for biomarkers that will predict response to IGF1R-targeted therapy.
-
Bruchim Ilan, Werner Haim, Targeting IGF-1 signaling pathways in gynecologic malignancies, Expert Opinion on Therapeutic Targets, 17, 3, 2013. Crossref
-
Gurwitz David, Expression profiling: a cost-effective biomarker discovery tool for the personal genome era, Genome Medicine, 5, 5, 2013. Crossref
-
Tian Dan, Kreeger Pamela K, Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy, BMC Systems Biology, 8, 1, 2014. Crossref
-
Tabernero Josep, Chawla Sant P., Kindler Hedy, Reckamp Karen, Chiorean E. Gabriela, Azad Nilofer S., Lockhart A. Craig, Hsu Cheng-Pang, Baker Nigel F., Galimi Francesco, Beltran Pedro, Baselga José, Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab, Targeted Oncology, 10, 1, 2015. Crossref
-
Hoppe Andreas, What mRNA Abundances Can Tell us about Metabolism, Metabolites, 2, 3, 2012. Crossref
-
Rota Lauren M., Wood Teresa L., Crosstalk of the Insulin-Like Growth Factor Receptor with the Wnt Signaling Pathway in Breast Cancer, Frontiers in Endocrinology, 6, 2015. Crossref
-
Bowers Laura W., Rossi Emily L., O’Flanagan Ciara H., deGraffenried Linda A., Hursting Stephen D., The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link, Frontiers in Endocrinology, 6, 2015. Crossref
-
Zhang Ting, Niu Xiaohua, Liao Lili, Cho Eun-Ah, Yang Haifeng, Fei Peiwen, The Contributions of HIF-Target Genes to Tumor Growth in RCC, PLoS ONE, 8, 11, 2013. Crossref
-
Erdem Cemal, Nagle Alison M., Casa Angelo J., Litzenburger Beate C., Wang Yu-fen, Taylor D. Lansing, Lee Adrian V., Lezon Timothy R., Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways, Molecular & Cellular Proteomics, 15, 9, 2016. Crossref
-
Obr Alison E., Kumar Sushil, Chang Yun-Juan, Bulatowicz Joseph J., Barnes Betsy J., Birge Raymond B., Lazzarino Deborah A., Gallagher Emily, LeRoith Derek, Wood Teresa L., Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment, Breast Cancer Research, 20, 1, 2018. Crossref
-
Özdamar Mustafa Yaşar, Şahin Sevinç, Zengin Kürşad, Seçkin Selda, Gürdal Mesut, Detection of insulin-like growth factor receptor-1 in the human cremaster muscle and its role in the etiology of the undescended testis, Asian Journal of Surgery, 42, 1, 2019. Crossref
-
Tabecka-Lonczynska Anna, Mytych Jennifer, Solek Przemyslaw, Kowalewski Mariusz P., Koziorowski Marek, Seasonal expression of insulin-like growth factor 1 (IGF-1), its receptor IGF-1R and klotho in testis and epididymis of the European bison (Bison bonasus, Linnaeus 1758), Theriogenology, 126, 2019. Crossref
-
Neirijnck , Papaioannou , Nef , The Insulin/IGF System in Mammalian Sexual Development and Reproduction, International Journal of Molecular Sciences, 20, 18, 2019. Crossref
-
Wang Jian, Xue Hong-Man, Chen Yan-Ru, Xu Hong-Gui, Lin Shao-Fen, Tang Xi-Kang, Chen Chun, Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia, Journal of Pediatric Hematology/Oncology, 41, 2, 2019. Crossref
-
Sarfstein Rive, Werner Haim, The INSR/IGF1R Receptor Family, in Receptor Tyrosine Kinases: Family and Subfamilies, 2015. Crossref
-
Sui Yi, Zhang Wei, Tang Tao, Gao Lili, Cao Ting, Zhu Hongbo, You Qinghua, Yu Bo, Yang Tao, Insulin-like growth factor-II overexpression accelerates parthenogenetic stem cell differentiation into cardiomyocytes and improves cardiac function after acute myocardial infarction in mice, Stem Cell Research & Therapy, 11, 1, 2020. Crossref
-
Jantrapirom Salinee, Lo Piccolo Luca, Pruksakorn Dumnoensun, Potikanond Saranyapin, Nimlamool Wutigri, Ubiquilin Networking in Cancers, Cancers, 12, 6, 2020. Crossref
-
Boone David N., Warburton Andrew, Som Sreeroopa, Lee Adrian V., SNHG7 is a lncRNA oncogene controlled by Insulin-like Growth Factor signaling through a negative feedback loop to tightly regulate proliferation, Scientific Reports, 10, 1, 2020. Crossref
-
Mikkelsen Jakob H., Resch Zachary T., Kalra Bhanu, Savjani Gopal, Kumar Ajay, Conover Cheryl A., Oxvig Claus, Indirect targeting of IGF receptor signalingin vivoby substrate-selective inhibition of PAPP-A proteolytic activity, Oncotarget, 5, 4, 2014. Crossref
-
Apostolou Panagiotis, Iliopoulos Aggelos C., Parsonidis Panagiotis, Papasotiriou Ioannis, Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma, Oncotarget, 10, 36, 2019. Crossref
-
Sarfstein Rive, Werner Haim, Minireview: Nuclear Insulin and Insulin-like Growth Factor-1 Receptors: A Novel Paradigm in Signal Transduction, Endocrinology, 154, 5, 2013. Crossref
-
Markowska Anna, Pawałowska Monika, Filas Violetta, Korski Konstanty, Gryboś Marian, Sajdak Stefan, Olejek Anita, Bednarek Wiesława, Śpiewankiewicz Beata, Lubin Jolanta, Markowska Janina, Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?, Diabetology & Metabolic Syndrome, 5, 1, 2013. Crossref
-
Karimi-Zarchi Mojgan, Zanbagh Leila, Javaheri Atiyeh, Tabatabaei Razieh Sadat, Abbasi Hajar, Meibodi Bahare, Hadadan Amaneh, Bahrami Reza, Mirjalili Seyed Reza, Neamatzadeh Hossein, Association of Insulin-like Growth Factor-II Apa1 and MspI Polymorphisms with Intrauterine Growth Restriction Risk, Fetal and Pediatric Pathology, 40, 6, 2021. Crossref
-
Tran Trang Thi Huyen, Nguyen Hoa Thi, Le Binh Thi Nguyen, Tran Phuc Huu, Van Nguyen Sang, Kim Oanh Thi Phuong, Characterization of single nucleotide polymorphism in IGF1 and IGF1R genes associated with growth traits in striped catfish (Pangasianodon hypophthalmus Sauvage, 1878), Aquaculture, 538, 2021. Crossref
-
Pal Kaushik, Sharma Aman, Koner Apurba L., Synthesis of Two-Photon Active Tricomponent Fluorescent Probe for Distinguishment of Biotin Receptor Positive and Negative Cells and Imaging 3D-Spheroid, Organic Letters, 20, 20, 2018. Crossref
-
Griffeth Richard J, Bianda Vanessa, Nef Serge, The emerging role of insulin-like growth factors in testis development and function, Basic and Clinical Andrology, 24, 1, 2014. Crossref
-
Erdem Cemal, Lee Adrian V., Taylor D. Lansing, Lezon Timothy R., Hall Benjamin, Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells, PLOS Computational Biology, 17, 6, 2021. Crossref
-
Bulatowicz Joseph J., Wood Teresa L., Activation Versus Inhibition of IGF1R: A Dual Role in Breast Tumorigenesis, Frontiers in Endocrinology, 13, 2022. Crossref
-
Nagle Alison M., Levine Kevin M., Tasdemir Nilgun, Scott Julie A., Burlbaugh Kara, Kehm Justin, Katz Tiffany A., Boone David N., Jacobsen Britta M., Atkinson Jennifer M., Oesterreich Steffi, Lee Adrian V., Loss of E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors, Clinical Cancer Research, 24, 20, 2018. Crossref
-
Sair Ali Tahir, Liu Rui Hai, Molecular regulation of phenolic compounds on IGF-1 signaling cascade in breast cancer, Food & Function, 13, 6, 2022. Crossref
-
Pei Xueying, Huo Fangjun, Yue Yongkang, Chen Tinggui, Yin Caixia, Cancer cell recognition by a Cys-reactive turn-on significant enhanced fluorescent emission targeting biotin receptors, Sensors and Actuators B: Chemical, 304, 2020. Crossref
-
Qadir Bhat Aadil, Owais Ayaz Mir, Hussain Razak, Dar Mohmmad Saleem, Hossain Md Mehedi, Showket Farheen, Dar Mohd Saleem, Akhter Yusuf, Dar Mohd Jamal, Identification of a stretch of four discontinuous amino acids involved in regulating kinase activity of IGF1R, Journal of Cell Science, 135, 13, 2022. Crossref
-
Kondo Takao, Aoki Hiromasa, Otsuka Yuto, Kawaguchi Yohei, Waguri-Nagaya Yuko, Aoyama Mineyoshi, Insulin-like growth factor 2 promotes osteoclastogenesis increasing inflammatory cytokine levels under hypoxia, Journal of Pharmacological Sciences, 149, 3, 2022. Crossref
-
Elangovan Ashuvinee, Hooda Jagmohan, Savariau Laura, Puthanmadhomnarayanan Susrutha, Yates Megan E., Chen Jian, Brown Daniel D., McAuliffe Priscilla F., Oesterreich Steffi, Atkinson Jennifer M., Lee Adrian V., Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma, Molecular Cancer Research, 20, 9, 2022. Crossref
-
Obr Alison E., Bulatowicz Joseph J., Chang Yun-Juan, Ciliento Virginia, Lemenze Alexander, Maingrette Krystopher, Shang Quan, Gallagher Emily J., LeRoith Derek, Wood Teresa L., Breast tumor IGF1R regulates cell adhesion and metastasis: alignment of mouse single cell and human breast cancer transcriptomics, Frontiers in Oncology, 12, 2022. Crossref